✦ LIBER ✦

Identifying activated hepatic stellate cells in chronic and posttransplant recurrent hepatitis C

✍ Scribed by Lisa Yerian

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21469

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glial fibrillary acidic protein as an ea

Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C

✍ Simone Carotti; Sergio Morini; Stefano Ginanni Corradini; Maria Antonella Burza; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Activated alpha-smooth muscle actin (alpha-SMA)-positive hepatic stellate cells (HSCs) are pericytes responsible for fibrosis in chronic liver injury. The glial fibrillary acidic protein (GFAP), commonly expressed by astrocytes in the central nervous system, is expressed in vivo in the liver in a su

Hepatic stellate cell activation in live

Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C

✍ Laura Cisneros; Maria-Carlota Londoño; Carmen Blasco; Ramón Bataller; Rosa Mique 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views

The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in

Early hepatic stellate cell activation p

Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation

✍ Samer Gawrieh; Bettina G. Papouchado; Lawrence J. Burgart; Shogo Kobayashi; Mich 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Only a subset of hepatitis C virus (HCV)-infected patients develop progressive hepatic fibrosis after liver transplantation (LT). Hepatic stellate cell (HSC) activation is a pivotal step in hepatic fibrosis and precedes clinically apparent fibrosis. We determined whether early HSC activation, measur

Incidence, risk factors, and outcome of

Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C

✍ Inmaculada Fernández; Esperanza Ulloa; Francisco Colina; Manuel Abradelo; Carlos 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Antiviral therapy for recurrent hepatitis C in liver transplantation has been associated with the development of chronic rejection. The aim of this study was to assess the incidence, evolution, and risk factors associated with the development of chronic rejection during posttransplant hepatitis C vi

Organic osmolyte transport in quiescent

Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (ito cells)

✍ Thorsten Peters-Regehr; Johannes G. Bode; Ralf Kubitz; Dieter Häussinger 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 1 views

Early hepatic stellate cell activation i

Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C

✍ Mark W. Russo; Roberto J. Firpi; David R. Nelson; Robert Schoonhoven; Roshan Shr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

Recurrent hepatitis C after liver transplantation is a serious problem faced by liver transplant recipients. Activation of hepatic stellate cells is an early step in hepatic fibrogenesis. The aim of this study was to evaluate hepatic stellate cell activation, early after liver transplantation, as a